Year: 2011
Type: article
Abstract: Aberrant Ras activity is a hallmark of diverse cancers and developmental diseases. Unfortunately, conventional efforts to develop effective small molecule Ras inhibitors have met with limited success. We have developed a novel multi-level computational approach to discover potential inhibitors of previously uncharacterized allosteric sites. Our approach couples bioinformatics analysis, advanced molecular simulations, ensemble docking and initial experimental testing of potential inhibitors. Molecular dynamics simulation highlighted conserved allosteric coupling of the nucleotide-binding switch region with distal regions, including loop 7 and helix 5. Bioinformatics methods identified novel transient small molecule binding pockets close to these regions and in the vicinity of the conformationally responsive switch region. Candidate binders for these pockets were selected through ensemble docking of ZINC and NCI compound libraries. Finally, cell-based assays confirmed our hypothesis that the chosen binders can inhibit the downstream signaling activity of Ras. We thus propose that the predicted allosteric sites are viable targets for the development and optimization of new drugs.
Source: PLoS ONE
Institutions: University of Michigan, Agency for Science, Technology and Research, University of Cambridge, Bioinformatics Institute, The University of Texas Health Science Center at Houston, University of California San Diego, Howard Hughes Medical Institute, Center for Theoretical Biological Physics
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,382
Funders: National Science Foundation, Howard Hughes Medical Institute, Agency for Science, Technology and Research, National Institutes of Health, Center for Theoretical Biological Physics, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of General Medical Sciences
OpenAlex ID: W2092973995
